Is Iodohipurato sodico (131 I) [INN-Spanish] Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use Iodohipurato sodico (131 I) [INN-Spanish]? Is Iodohipurato sodico (131 I) [INN-Spanish] safe for nursing mother and child? Does Iodohipurato sodico (131 I) [INN-Spanish] extracts into breast milk? Does Iodohipurato sodico (131 I) [INN-Spanish] has any long term or short term side effects on infants? Can Iodohipurato sodico (131 I) [INN-Spanish] influence milk supply or can Iodohipurato sodico (131 I) [INN-Spanish] decrease milk supply in lactating mothers?

Information in this record refers to the use of Iodohipurato sodico (131 I) [INN-Spanish] (ortho-Iodohipurato sodico (131 I) [INN-Spanish]; I-131 OIH) as a diagnostic agent. The United States Nuclear Regulatory Commission states that breastfeeding need not be interrupted after administration of I-131 OIH in doses up to 10 MBq (0.3 mCi) to a nursing mother.[1] However, some experts recommend nursing the infant just before administration of the radiopharmaceutical and interrupting breastfeeding for 12 to 30 hours after the dose.[2][3][4] If the mother has expressed and saved milk prior to the examination, she can feed it to the infant during the period of nursing interruption.[2][5][6] Mothers concerned about the level of radioactivity in their milk could ask to have it tested at a nuclear medicine facility at their hospital. When the radioactivity is at a safe level she may resume breastfeeding. A method for measuring milk radioactivity and determining the time when a mother can safely resume breastfeeding has been published.[7] Nursing mothers should not work with substances containing I 131 in their workplace.[8]